secwatch / observer
ISCO International Stem Cell CORP
CIK 0001355790 17 ready 8-Ks latest September 8, 2026, 4:03 PM ET RSS · JSON
Activity: NORMAL 0 filings / 30d vs 0 baseline
Ready 8-Ks 17
Latest filing September 8, 2026, 4:03 PM ET
Top materiality 0.75
Event mix debt ×7 · other_material ×4 · m_and_a ×2
Sentiment 0 pos · 1 neg · 16 neu
Executive change recent →

Recent 8-K filings for ISCO

Executive changes

Appointed

Russell Kern

principal financial officer
ISCO · International Stem Cell CORP
Effective
2022-04-25
Filed
April 29, 2022, 7:59 PM ET
On April 25, 2022, International Stem Cell Corporation, a Delaware corporation (the “Company”) appointed Dr. Russell Kern as its principal financial officer effective immediately.
Departed

Sophia Garnette

Principal Financial Officer and VP of Legal Affairs and Operations
ISCO · International Stem Cell CORP
Effective
2022-04-01
Filed
February 2, 2022, 6:59 PM ET
On February 1, 2022, Sophia Garnette, Principal Financial Officer and VP of Legal Affairs and Operations of International Stem Cell Corporation (the "Company"), submitted her resignation, to be effective on April 1, 2022.

Materiality & sentiment trend

Max materiality 0.75 · Median 0.45 · Most common event debt

0 positive 1 negative 16 neutral

source · ISCO on sec.gov